| 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7) F Cardoso, S Paluch-Shimon, E Schumacher-Wulf, L Matos, K Gelmon, ... The Breast 76, 103756, 2024 | | 2024 |
| A prospective multicentre cohort study of colorectal lung metastasectomy with a nested randomized controlled trial: the key points from the pulmonary metastasectomy in … T Treasure, F Macbeth, L Fallowfield European Journal of Cardio-Thoracic Surgery 65 (6), 2024 | | 2024 |
| Roll out and influence of an educational program: Talking about risk, uncertainties of testing in genetics (TRUSTING). VA Jenkins, R Habibi, V Hall, P Leonard, A Lawn, J Naik, ... Journal of Clinical Oncology 42 (16_suppl), 9025-9025, 2024 | | 2024 |
| Improving patient understanding of GEP test results (IMPARTER4): An RCT. L Fallowfield, I Solis-Trapala, R Starkings, L Matthews, S May, VA Jenkins Journal of Clinical Oncology 42 (16_suppl), 527-527, 2024 | | 2024 |
| Abstract PO3-11-12: A Pragmatic Randomized Trial Comparing Morning versus Evening Dosing of Endocrine Therapy for Early Breast Cancer: Final Results (REaCT-CHRONO Study) MF Savard, M Ibrahim, G Pond, D Saunders, L Vandermeer, L Fallowfield, ... Cancer Research 84 (9_Supplement), PO3-11-12-PO3-11-12, 2024 | | 2024 |
| 71P Patient-reported understanding of biomarkers associated with metastatic breast cancer (mBC) diagnosis: Results from a global mBC survey in 36 countries E Schumacher-Wulf, L Fallowfield, RCW Chidebe, V Durston, A Eniu, ... ESMO Open 9, 2024 | | 2024 |
| Endocrine and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer—Capivasertib-Fulvestrant: ASCO Rapid … HJ Burstein, A DeMichele, L Fallowfield, MR Somerfield, NL Henry, ... Journal of Clinical Oncology 42 (12), 1450-1453, 2024 | 1 | 2024 |
| Estimating the Ovarian Cancer CA-125 Preclinical Detectable Phase, In-Vivo Tumour Doubling Time, and Window for Detection in Early Stage: An Exploratory Analysis of UKCTOCS JS Bedia, IJ Jacobs, A Ryan, A Gentry-Maharaj, M Burnell, R Manchanda, ... | | 2024 |
| BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial B Torr, C Jones, G Kavanaugh, M Hamill, S Allen, S Choi, A Garrett, ... medRxiv, 2024.05. 03.24306669, 2024 | | 2024 |
| Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer–An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) J Dilley, A Gentry-Maharaj, A Ryan, M Burnell, R Manchanda, J Kalsi, ... Gynecologic Oncology 179, 123-130, 2023 | 2 | 2023 |
| Removal or ablation of asymptomatic lung metastases should be reconsidered F Macbeth, L Fallowfield, E Treasure, I Ahmad, Y Zheng, T Treasure bmj 383, 2023 | 2 | 2023 |
| Recruiting women with ductal carcinoma in situ to a randomised controlled trial: lessons from the LORIS study S Wheelwright, L Matthews, V Jenkins, S May, D Rea, P Fairbrother, ... Trials 24 (1), 670, 2023 | 2 | 2023 |
| BP52 DEVELOPMENT OF AN INFORMATION FILM FOR FRIENDS AND FAMILY OF PATIENTS WITH MBC “THEY JUST DON’T KNOW WHAT TO SAY OR DO” V Jenkins, L Stephen, A Tait, C Palmieri, R Starkings, R Habibi, ... The Breast 71, S31, 2023 | | 2023 |
| LBA101 BRCA-DIRECT: A randomised UK study evaluating a digital pathway for germline genetic testing and non-inferiority of digitally-delivered information in women with breast … B Torr, S Choi, S Allen, M Hamill, G Kavanaugh, S MacMahon, ... Annals of Oncology 34, S1339, 2023 | | 2023 |
| Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial U Menon, A Gentry-Maharaj, M Burnell, A Ryan, N Singh, R Manchanda, ... The Lancet Oncology 24 (9), 1018-1028, 2023 | 9 | 2023 |
| Insights from UKCTOCS for design, conduct and analyses of large randomised controlled trials U Menon, A Gentry-Maharaj, M Burnell, S Apostolidou, A Ryan, JK Kalsi, ... Health Technology Assessment, 1-38, 2023 | | 2023 |
| Living with metastatic breast cancer (LIMBER): experiences, quality of life, gaps in information, care and support of patients in the UK L Fallowfield, R Starkings, C Palmieri, A Tait, L Stephen, S May, R Habibi, ... Supportive Care in Cancer 31 (8), 459, 2023 | 7 | 2023 |
| 19 Psychosocial issues in breast cancer V Jenkins, L Fallowfield Breast Surgery: Breast Surgery-E-Book, 218, 2023 | | 2023 |
| Why Did Downstaging in the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Not Result in a Mortality Benefit: Exploratory Analysis of a Randomised … U Menon, A Gentry-Maharaj, M Burnell, A Ryan, N Singh, R Manchanda, ... | | 2023 |
| Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial. U Menon, A Gentry-Maharaj, M Burnell, A Ryan, JK Kalsi, N Singh, ... Health Technology Assessment (Winchester, England), 1, 2023 | 9 | 2023 |
